ATM and CHEK2 are examples of moderate-penetrance genes with lower lifetime risk of developing breast cancer as compared to the high-penetrance genes BRCA1 and BRCA2, and these moderate-penetrance genes account for around 6% of HBC [11]. This evidence concerns the gene CHEK2 and breast cancer.